Isolated focal cortical dysplasia type IIb

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:269008OMIM:607341Q04.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Isolated focal cortical dysplasia type IIb (FCD IIb) is a rare malformation of cortical development characterized by a localized area of abnormal brain architecture. In this condition, a region of the cerebral cortex contains disorganized layers (cortical dyslamination) along with two hallmark cell types: dysmorphic neurons and balloon cells. These abnormal cells result from disrupted neuronal migration and differentiation during fetal brain development. FCD IIb is classified under the International League Against Epilepsy (ILAE) focal cortical dysplasia classification system and is one of the most common causes of drug-resistant focal epilepsy, particularly in children and young adults. The primary clinical manifestation of isolated FCD IIb is epilepsy, often presenting with focal seizures that may secondarily generalize. Seizures frequently begin in childhood, though onset can occur at any age depending on the location and extent of the lesion. The seizure semiology depends on which brain region is affected. Patients may also experience developmental delay, cognitive difficulties, or focal neurological deficits, though some individuals have normal development apart from their seizures. On MRI, FCD IIb typically shows a thickened cortex with blurring of the gray-white matter junction and a characteristic "transmantle sign" — a hyperintense signal on T2/FLAIR sequences extending from the cortex toward the ventricle. The condition is considered sporadic in most cases, though somatic mutations in the mTOR signaling pathway (particularly in genes such as MTOR, TSC1, TSC2, and DEPDC5) have been identified in resected tissue, linking FCD IIb to the broader spectrum of mTORopathies. Treatment centers on seizure control. Many patients are refractory to antiseizure medications, making surgical resection of the dysplastic lesion the most effective treatment option, with seizure-freedom rates of 60–80% when complete resection is achieved. Presurgical evaluation typically involves video-EEG monitoring, high-resolution MRI, and sometimes invasive electrode monitoring to precisely delineate the epileptogenic zone.

Also known as:

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Isolated focal cortical dysplasia type IIb.

View clinical trials →

No actively recruiting trials found for Isolated focal cortical dysplasia type IIb at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Isolated focal cortical dysplasia type IIb community →

No specialists are currently listed for Isolated focal cortical dysplasia type IIb.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Isolated focal cortical dysplasia type IIb.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Isolated focal cortical dysplasia type IIbForum →

No community posts yet. Be the first to share your experience with Isolated focal cortical dysplasia type IIb.

Start the conversation →

Latest news about Isolated focal cortical dysplasia type IIb

No recent news articles for Isolated focal cortical dysplasia type IIb.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Isolated focal cortical dysplasia type IIb

What is Isolated focal cortical dysplasia type IIb?

Isolated focal cortical dysplasia type IIb (FCD IIb) is a rare malformation of cortical development characterized by a localized area of abnormal brain architecture. In this condition, a region of the cerebral cortex contains disorganized layers (cortical dyslamination) along with two hallmark cell types: dysmorphic neurons and balloon cells. These abnormal cells result from disrupted neuronal migration and differentiation during fetal brain development. FCD IIb is classified under the International League Against Epilepsy (ILAE) focal cortical dysplasia classification system and is one of the

How is Isolated focal cortical dysplasia type IIb inherited?

Isolated focal cortical dysplasia type IIb follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.